Figure 1. General strategy of chromatographic steps in the purification process of commercial Fc-fusion proteins produced in mammalian cells culture. (Sánchez-Trasviña et al, 2021)
1. DNA and HCP Are Heterogeneous Populations
Residual host-cell DNA varies in length, conformation, association with proteins or particles, and degree of fragmentation. Its phosphate backbone gives strong negative charge over common bioprocess pH ranges, making anion exchange a logical removal mechanism. However, large DNA can increase viscosity and bridge proteins or particles, while short fragments may show different pore access and breakthrough.
Host cell proteins comprise thousands of species with different abundance, pI, hydrophobicity, size, stability, and affinity for the product or resin. A total-HCP assay measures the recognized population but does not explain which individual proteins persist. Some HCPs are difficult to remove because they associate with product, lipids, DNA, or aggregates.
2. Ion Exchange Can Clear Impurities by Several Mechanisms
| Mechanism | Product behavior | Impurity behavior | Development implication |
|---|---|---|---|
| Anion-exchange flow-through | Product passes or weakly partitions | DNA and negatively charged HCPs bind | Control impurity breakthrough and unintended product retention |
| Cation-exchange bind-and-elute | Product binds and is washed/eluted | DNA and many acidic HCPs pass or wash away | Optimize wash without product loss; monitor co-bound basic HCPs |
| Anion-exchange bind-and-elute | Acidic product binds | DNA and HCPs may compete or separate during wash/elution | Capacity and selectivity can be dominated by nucleic acid |
| Orthogonal sequence | Product and impurities encounter more than one mechanism | Different impurity subsets are removed at different steps | Measure cumulative and step-specific clearance |
A single ion-exchange step rarely removes every HCP. The objective should identify the impurity class controlled by the step and how adjacent affinity, hydrophobic, size-based, filtration, or precipitation operations complement it.
3. Choose the Operating Mode and Resin
For anion-exchange flow-through, select pH and conductivity where product recovery is high and impurity binding is strong. A strong anion exchanger can provide predictable positive ligand charge across a broad range. Weak anion exchangers may add selectivity but can be more sensitive to pH. Matrix pores and ligand density influence DNA capacity, especially for large fragments.
For cation-exchange capture, select conditions where product binds while DNA and many acidic contaminants do not. Wash salt or pH can remove weakly bound HCP before product elution. This strategy also concentrates product but places product quality at risk during elution.
Compare finished resins by impurity capacity, product recovery, pressure, fouling, and cleanability. Creative BioMart provides ion exchange chromatography media and method development and optimization.
4. Condition the Feed Without Hiding the Impurity Problem
Clarification and depth filtration reduce particles and large complexes that can foul a packed bed. Nuclease treatment may reduce viscosity and DNA size, improving handling, but smaller fragments may have different binding and breakthrough. Precipitation or flocculation can reduce bulk DNA and HCP before chromatography but may alter the residual population.
Measure pH, conductivity, turbidity, product concentration, DNA, and HCP after conditioning. Dilution can improve impurity binding but increases volume. Buffer exchange can remove competing salts but adds recovery risk. Product–HCP and product–DNA complexes may change with pH and salt; a condition that releases an impurity from product can make it easier to bind to the resin.
Avoid spiking purified impurity into clean product as the only model. Spikes can support mechanistic studies, but process-derived impurities may have different size, association, and accessibility.
5. DNA-Specific Development Factors
DNA size distribution affects diffusion and accessible capacity. Very large DNA may be excluded from smaller pores yet bind strongly to external surfaces, creating rapid local saturation or pressure effects. Fragmented DNA can enter more pores, increasing capacity but possibly changing breakthrough shape. Sample shear and nuclease history should be controlled.
pH and conductivity influence DNA binding and its complexes with proteins. Higher conductivity generally weakens electrostatic capture. Host proteins can compete for sites or mask DNA. The relationship is not always monotonic because complex dissociation can expose additional DNA at changed salt.
Measure DNA in load, flow-through fractions, wash, and strip. Total DNA concentration alone does not describe fragment size. When clearance is critical, include a size-distribution method or qualified surrogate during development and justify the analytical sensitivity.
6. HCP-Specific Development Factors
HCP binding depends on individual charge and on association with product or other feed components. Anion-exchange flow-through preferentially binds more negative HCPs, while basic HCPs may pass. Cation-exchange product capture may co-bind basic HCPs or product-associated species. Aggregate-associated HCP can follow the product across multiple steps.
Total-HCP immunoassays have coverage and matrix limitations. Dilution, product concentration, and buffer can affect recovery. Use qualified sample preparation, spike recovery, and dilutional parallelism as appropriate. Targeted mass spectrometry or specific assays can identify persistent high-risk HCPs that a total assay cannot resolve.
Wash development should follow individual or total HCP trends alongside product recovery. A wash that reduces total HCP may enrich one strongly associated species, so orthogonal analysis is valuable when process knowledge identifies difficult proteins.
7. Measure Breakthrough With a Relevant Impurity Challenge
For flow-through operation, define capacity by the impurity that controls failure. Load product-containing feed at representative and high DNA/HCP levels, collect sequential flow-through fractions, and plot impurity concentration or cumulative breakthrough versus load. Include the displacement wash because late impurity can enter the product pool.
Challenge pH, conductivity, residence time, and feed variability. If product mass is constant but impurity titer varies, a product-based load limit may be unsafe. Establish a conservative loading rule connected to upstream controls or at-line impurity measurement.
8. Build a Mass Balance and Clearance Assessment
| Measurement | Purpose | Caution |
|---|---|---|
| Product concentration and recovery | Detects unintended product binding or loss | Assay must be valid in load and pool matrices |
| Residual DNA concentration | Quantifies step clearance and pool level | Sensitivity and sample preparation can limit low-level results |
| DNA size distribution | Explains transport and capacity changes | Method must cover relevant fragment range |
| Total HCP | Tracks broad process impurity population | Antibody coverage and matrix effects |
| Specific HCP or proteomics | Identifies persistent or high-risk species | Requires representative sampling and fit-for-purpose quantitation |
| Pressure and turbidity | Detects fouling and particle/complex load | A stable pressure does not prove impurity capacity remains |
Report step reduction with input and output values, assay limits, and recoveries. A result below quantitation should not be assigned an exact clearance value without appropriate treatment. Include resin strip or cleaning fractions when closing impurity mass balance during development.
9. Robustness, Cleaning, and Lifecycle
Test high and low pH, conductivity, residence time, product load, DNA, and HCP within credible process ranges. Include feed age or hold when it changes DNA size or complex formation. Track product recovery and both impurity classes; a condition that improves DNA may worsen HCP or product retention.
DNA and HCP fouling can reduce impurity capacity before pressure changes. Cycle studies should monitor breakthrough, product recovery, pressure, and cleaning effectiveness. A strong cleaning condition may remove nucleic acid but damage the matrix or functional group. Define storage and microbial controls for reusable media.
10. Impurity-Clearance Control Record
Record cell line or host, upstream and clarification history, feed pH, conductivity, product titer, DNA concentration and size information, HCP result, resin, column, load, residence time, pool boundaries, wash, strip, cleaning, and analytics. Identify the impurity that limits load.
The control strategy should state feed acceptance ranges, maximum processed volume or impurity challenge, sampling points, breakthrough response, product-recovery range, and actions for out-of-range DNA or HCP. Connect the ion-exchange step to cumulative process clearance rather than treating it as an isolated claim.
Integrate clearance across the process
Map where DNA and major HCP populations are reduced before and after ion exchange. An upstream nuclease or precipitation step can reduce load but change fragment size or expose previously complexed HCP. A selective capture step can lower total HCP while enriching product-associated species. Use step-specific data to choose the role of ion exchange rather than demanding complete clearance from one column.
Consider pool composition for the next step. A high-salt cation-exchange eluate may weaken subsequent anion binding unless diluted or exchanged. A large flow-through pool may require concentration. These transitions can change impurity complexes, so measure DNA and HCP after conditioning as well as immediately after the column.
When calculating cumulative reduction, handle results below assay quantitation appropriately and avoid adding unsupported log-reduction values. Include product recovery and sample-volume changes. A robust process controls the final residual level with complementary mechanisms and monitored inputs, not the largest single nominal clearance number.
Integrate Impurity Clearance Across the Process
Map where DNA and HCP populations are reduced before and after ion exchange. Nuclease or precipitation can reduce load while changing DNA size or exposing complexed HCP. Selective capture may lower total HCP while enriching product-associated species. Assign ion exchange a defined role instead of demanding complete clearance from one column.
Consider transitions. A high-salt cation-exchange eluate may weaken subsequent anion binding unless diluted or exchanged; a large flow-through pool may need concentration. These operations can alter impurity complexes, so measure DNA and HCP after conditioning as well as immediately after the column.
Use process-derived impurity when possible. If spiking is needed, justify source, size, association state, and level, and show that the spike does not unrealistically change feed properties. Control sample storage, vessels, dilution, assay recovery, and matrix interference so apparent clearance is not created by analytical loss.
Connect this guide to your ion exchange project
Share the target, feed composition, scale, stability limits, required purity, important impurities, current chromatogram, and operating constraints. Our team can help evaluate media or develop a purification workflow.
References
- Stone MC, Carta G. Effects of pH, conductivity, host cell protein, and DNA size distribution on DNA clearance in anion exchange chromatography media. Biotechnol Prog. 2018;34:112–126.
- Shukla AA, Hinckley P. Host cell protein clearance during protein A chromatography: development of an improved column wash step. Biotechnol Prog. 2008;24:1115–1121.
- Gagnon P. Technology trends in antibody purification. J Chromatogr A. 2012;1221:57–70.
- Sánchez-Trasviña C, Flores-Gatica M, Enriquez-Ochoa D, Rito-Palomares M, Mayolo-Deloisa K. Purification of modified therapeutic proteins available on the market: an analysis of chromatography-based strategies. Front Bioeng Biotechnol. 2021;9:717326.
